CUSTOMER SUPPORT CUSTOMER SUPPORT 022-4603 7236

fund search

Individually analyse each scheme and narrow your options further Every minute detail you need to know about scheme of your choice from asset holdings, best and worst performance and fund returns to competitor analysis; is available in the Fund card.
Using this report card, you can gather vital information regarding the future health of the scheme by analysing the top 10 companies and sectors it invests in. You can also track the fund management’s track record and analyse the philosophy behind scheme’s holdings. All the parameters in the fund card are extremely important and can go a long way in helping you decide which scheme to invest your money.

NAV As on Dec-20-2024

HDFC Pharma and Healthcare Fund(G)-Direct Plan

Top 10 Holdings
Company
(%)
Sun Pharmaceutical Industries Ltd.
13.48
Divi's Laboratories Ltd.
7.85
Cipla Ltd.
7.75
Lupin Ltd.
5.80
Gland Pharma Ltd.
3.99
Ipca Laboratories Ltd.
3.75
Aster DM Healthcare Ltd.
3.57
Vijaya Diagnostic Centre Ltd.
3.54
Eris Lifesciences Ltd.
3.38
Glenmark Pharmaceuticals Ltd.
3.37
Top 10 Sectors
Sectors
(%)
Pharmaceuticals & Drugs
78.88
Hospital & Healthcare Services
17.81
Business Support
1.52
Asset Allocation
Market Cap Allocation
  Scheme Benchmark ()
Large-Cap 36.92 NA
Mid-Cap 27.20 NA
Small-Cap 34.10 NA

Best and Worst Performance and Ratios

Best Performance in a year
Period Fund (%) Benchmark (%)
Year 31/10/23
to 31/10/24
67.32NA
Worst Performance in a year
Period Fund (%) Benchmark (%)
Year 17/11/23
to 18/11/24
51.27NA
Ratios
Standard Deviation[%] 15.66
Sharpe Ratio [%] 0.99
Turnover Ratio [%] 56.44
Modified Duration
YTM
Riskometer
very high risk

Investors understand that their principal will be at very high risk

Fund Details
Category
Sector Funds
Inception Date (Regular Plan)
04-Oct-23
Inception Date (Direct Plan)
04-Oct-23
Expense Ratio (Direct Plan) %
0.94
Expense Ratio (Regular Plan) %
2.17
Investing Style
Large Growth
Fund Manager
Nikhil Mathur
Scheme Benchmark
BSE HEALTH CARE - TRI
AUM (Rs. in Cr.)
1,459.59
Fund Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Growth Chart of the Scheme Versus Benchmark (SIP value Rs10,000)
HDFC Pharma and Healthcare Fund(G)-Direct Plan BSE Health Care - TRI

Performance Comparison with similar Schemes and Benchmark